These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17068275)

  • 21. Conclusions and recommendations of the IVth Joint Meeting on Leishmania/HIV co-Infections. Catania, Italy, 17-18 May 2001.
    Parasite; 2001 Dec; 8(4):376-9. PubMed ID: 11802278
    [No Abstract]   [Full Text] [Related]  

  • 22. Alkaloids: future prospective to combat leishmaniasis.
    Mishra BB; Kale RR; Singh RK; Tiwari VK
    Fitoterapia; 2009 Mar; 80(2):81-90. PubMed ID: 19015012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atypical presentation and fatal evolution of visceral leishmaniasis in a patient infected with HIV].
    Muńiz Grijalvo O; Losada Vińau J; Rizo Valero A; Miranda Guisado ML
    Rev Clin Esp; 1991 Jul; 189(3):151-2. PubMed ID: 1947393
    [No Abstract]   [Full Text] [Related]  

  • 25. Fine needle aspiration of a lymph node in an HIV patient with chronic infection by Leishmania: a case report.
    de Faria FB; Barroca H
    Acta Cytol; 2010; 54(5 Suppl):946-8. PubMed ID: 21053575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis.
    Matheron S; Cabié A; Parquin F; Mayaud C; Roux P; Antoine M; Chougnet C; Coulaud JP
    AIDS; 1992 Feb; 6(2):238-40. PubMed ID: 1558727
    [No Abstract]   [Full Text] [Related]  

  • 27. [Visceral leishmaniasis in patients with HIV infection. Our experience].
    Terra L; Pellicanò S; Allò M
    Minerva Med; 1996 Jun; 87(6):317-9. PubMed ID: 8700361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmaniasis vaccine candidates for development: a global overview.
    Khamesipour A; Rafati S; Davoudi N; Maboudi F; Modabber F
    Indian J Med Res; 2006 Mar; 123(3):423-38. PubMed ID: 16778321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV/AIDS and leishmaniasis coinfection in Ethiopia.
    Arya SC; Agarwal N
    CMAJ; 2005 Oct; 173(9):1067; author reply 1070. PubMed ID: 16247107
    [No Abstract]   [Full Text] [Related]  

  • 30. Leishmaniasis chemotherapy--challenges and opportunities.
    Croft SL; Olliaro P
    Clin Microbiol Infect; 2011 Oct; 17(10):1478-83. PubMed ID: 21933306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania amastigotes visualized on bone marrow aspirate in a leishmaniasis and HIV coinfected patient presenting with pancytopenia.
    Dittus C; Semmel D
    Blood; 2013 Dec; 122(26):4162. PubMed ID: 24501759
    [No Abstract]   [Full Text] [Related]  

  • 32. Leishmania / HIV co-infections.
    Desjeux P
    Afr Health; 1995 Nov; 18(1):20-2. PubMed ID: 12290565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating HIV/AIDS and leishmaniasis coinfection in Ethiopia.
    Anema A; Ritmeijer K
    CMAJ; 2005 May; 172(11):1434-5. PubMed ID: 15911851
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis of clinical samples spotted on FTA cards using PCR-based methods.
    Jamjoom M; Sultan AH
    J Egypt Soc Parasitol; 2009 Apr; 39(1):227-46. PubMed ID: 19530624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats.
    Bogdan C
    Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i60-6. PubMed ID: 22460140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical aspects of visceral leishmaniasis in HIV infection.
    Jarvis JN; Lockwood DN
    Curr Opin Infect Dis; 2013 Feb; 26(1):1-9. PubMed ID: 23221770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
    Antinori S; Calattini S; Longhi E; Bestetti G; Piolini R; Magni C; Orlando G; Gramiccia M; Acquaviva V; Foschi A; Corvasce S; Colomba C; Titone L; Parravicini C; Cascio A; Corbellino M
    Clin Infect Dis; 2007 Jun; 44(12):1602-10. PubMed ID: 17516404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Visceral leishmaniasis and immunosuppression].
    Lortholary O; Christiaens D; Mechali D; Babinet P
    Ann Med Interne (Paris); 1991; 142(3):215-7. PubMed ID: 1854134
    [No Abstract]   [Full Text] [Related]  

  • 39. [Multiple skin nodules, pancytopenia, and a solitary lung nodule in an HIV-infected patient].
    Ojeda G; López N; González M; Márquez M
    Enferm Infecc Microbiol Clin; 2010; 28(6):389-91. PubMed ID: 19729227
    [No Abstract]   [Full Text] [Related]  

  • 40. [Disseminated cutaneous leishmaniasis revealing human immunodeficiency virus infection].
    Durand I; Beylot-Barry M; Weill FX; Doutre MS; Beylot C
    Ann Dermatol Venereol; 1998 Apr; 125(4):268-70. PubMed ID: 9747266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.